Inteliquet

Executive Summary

Inteliquet is a digital health company specializing in AI-powered clinical trial matching for oncology. By leveraging real-world data and artificial intelligence, the company's platform connects patients with appropriate clinical trials, addressing a critical bottleneck in cancer research: slow patient enrollment. Inteliquet serves pharmaceutical sponsors, contract research organizations (CROs), and healthcare providers, aiming to accelerate trial recruitment and improve patient access to novel therapies. Founded in 2015 and based in Philadelphia, the company operates at the intersection of oncology, digital health, and AI/ML. While financial details and stage are not disclosed, Inteliquet's focus on a high-need area positions it as a potential player in the clinical trial optimization market. The company's ability to demonstrate improved enrollment metrics and secure partnerships with key stakeholders will be critical to its growth and impact.

Upcoming Catalysts (preview)

• Q4 2026Major Pharma Partnership or Collaboration40% success
• Q1 2027Series B or Significant Funding Round50% success
• TBDPlatform Expansion into New Therapeutic Areas30% success